Cargando…
Sustained activation of the renin–angiotensin–aldosteron system after fetal exposure to AT1 blockers: Effects on kidney and bone in a preterm newborn
The renin–angiotensin–aldosterone system (RAAS) plays a key role in development of fetal kidney. Angiotensin‐converting enzyme (ACE) inhibitors or angiotensin II receptor type 1 (AT1) antagonists alter RAAS‐signaling compromising metanephrogenesis, and vascular and tubular development. The result is...
Autores principales: | D'Amato, Gabriele, Rembouskos, Georgios, Cafagna, Rosa, Dentico, Domenico, Palladino, Stefano, Chiarito, Mariangela, Faienza, Maria Felicia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons Australia, Ltd
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10087169/ https://www.ncbi.nlm.nih.gov/pubmed/36098242 http://dx.doi.org/10.1111/jog.15427 |
Ejemplares similares
-
Congenital hypothyroidism after newborn screening program reorganization in the Apulia region
por: Simonetti, Simonetta, et al.
Publicado: (2022) -
Renin–Angiotensin–Aldosterone System Blockers and the Risk of Covid-19
por: Mancia, Giuseppe, et al.
Publicado: (2020) -
Clinical Implication of the Renin-angiotensin-aldosterone Blockers in Chronic Kidney Disease Undergoing Hemodialysis
por: Morishita, Yoshiyuki, et al.
Publicado: (2014) -
Meta-analysis of effect of renin–angiotensin–aldosterone system blockers on contrast-induced nephropathy
por: Wang, Weidong, et al.
Publicado: (2020) -
Should we continue to use renin–angiotensin–aldosterone system blockers in patients with COVID-19?
por: Copur, Sidar, et al.
Publicado: (2022)